Disruptive technologies transforming upstream process intensification for all modalities

Opportunities to gain significant product yield and improve process efficiency exist today for nearly all modalities. Process intensification has been proven to lower cost of goods, increase productivity, reduce facility footprint, and increase throughput. This webinar highlights how the XCell ATF^® and KrosFlo^® TFDF^® cell retention technologies are used to enable upstream process intensification. Industry case studies will be shown for multiple modalities including recombinant proteins, viral vectors and vaccines. Quantifiable improvements in yield, cost reduction and/or time are included.